Dania Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.42M
- Investors
-
6
Dania Therapeutics General Information
Description
Developer of medicinal products designed for cancer and other related conditions. The company develops novel small-molecule therapies to treat acute myeloid leukemia (AML) and other life-threatening cancers, enabling doctors to treat cancer patients.
Contact Information
Corporate Office
- C/O Nyborg & Rørdam Law Firm
- Store Kongensgade 77
- 1264 Copenhagen
- Denmark
Corporate Office
- C/O Nyborg & Rørdam Law Firm
- Store Kongensgade 77
- 1264 Copenhagen
- Denmark
Dania Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 18-Oct-2023 | $2.42M | Completed | Pre-Clinical Trials | ||
| 1. Joint Venture | 31-Oct-2021 | Completed | Pre-Clinical Trials |
Dania Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Dania Therapeutics Patents
Dania Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025208385-A1 | Wnk1 inhibitors | Pending | 10-Jan-2024 | ||
| WO-2025149622-A1 | Wnk1 inhibitors | Inactive | 10-Jan-2024 | ||
| WO-2025149623-A1 | Wnk1 inhibitors | Inactive | 10-Jan-2024 | C07D471/04 |
Dania Therapeutics Signals
Dania Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Denmark's Export and Investment Fund | Venture Capital | Minority | ||
| Eir Ventures | Venture Capital | Minority | ||
| Lundbeckfonden BioCapital | Venture Capital | Minority | ||
| University of Copenhagen | University | Minority | ||
| Hannibal Innovation | Corporation | Majority |
Dania Therapeutics FAQs
-
When was Dania Therapeutics founded?
Dania Therapeutics was founded in 2021.
-
Where is Dania Therapeutics headquartered?
Dania Therapeutics is headquartered in Copenhagen, Denmark.
-
What is the size of Dania Therapeutics?
Dania Therapeutics has 1 total employees.
-
What industry is Dania Therapeutics in?
Dania Therapeutics’s primary industry is Drug Discovery.
-
Is Dania Therapeutics a private or public company?
Dania Therapeutics is a Private company.
-
What is the current valuation of Dania Therapeutics?
The current valuation of Dania Therapeutics is .
-
What is Dania Therapeutics’s current revenue?
The current revenue for Dania Therapeutics is .
-
How much funding has Dania Therapeutics raised over time?
Dania Therapeutics has raised $2.42M.
-
Who are Dania Therapeutics’s investors?
Denmark's Export and Investment Fund, Eir Ventures, Lundbeckfonden BioCapital, University of Copenhagen, and Hannibal Innovation are 5 of 6 investors who have invested in Dania Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process